UPDATE: We are starting to write prescriptions for the Freestye Libre system. The sensor will last 10-days and have a 12-hour warm-up period and are expected to cost less than existing sensors. The reader also doubles as a meter that will accept FreeStyle Precision Neo blood glucose test strips. The system will be available at many local pharmacies and insurance coverage is not expected to be available until sometime next year.


The Libre

The first fully fingerstick replacement sensor has been approved by the FDA in September. The Abbott Libre is expected to be available in the US by the end of the year. It was launched in Europe and for the past few years it has been hard to keep up with the demand. Patients love it, but is it right for you?

What it is?

1.  A continuous glucose sensor that is worn on the arm or abdomen.

2.  The user can see what the blood sugar level is by swiping a reader over it.

3. It is factory calibrated - NO fingersticks are required.

4.  The reader shows you a blood sugar level and whether your sugars are rising, falling or staying flat.

5.  It does NOT provide any alarms or alerts when the blood sugar is rising or falling, so the Dexcom or Medtronic sensors may be a better choice for people already on a sensor or who need alerts to low blood sugar levels.

We have experience using the blinded pro-version of the Libre and have been working with patients who have picked up the European version in their travels. For those of you not on a continuous glucose monitor or who dislike doing fingersticks this will be a wonderful option.

Want to know more? Watch the video by Dr. Peters on Medscape:

Faster Acting Insulin

The FDA recently approved Fiasp, a faster acting version of insulin aspart - or Novolog. This insulin starts working more rapidly than Humalog or Novolog, so that it better matches the absorption of food. It also wears off a little more quickly, avoiding some of the low blood sugars seen with the older insulins. It is best suited for patients who use a continuous glucose monitors and are on pre-meal injections or a pump. Although it is not yet approved for pump use, it will be available in either a pen or a vial. It will help with the frustration of being “stuck high” after eating or having to give an insulin injection 15 – 30 minutes before a meal. It can be given immediately before eating or even during the meal. It should be available in the US in January and is priced similar to Novolog.

Want to know more? Watch the video by Dr. Peters on Medscape: